{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:58:39Z","timestamp":1777726719918,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Med Res"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:p>Preventive measures for human immunodeficiency virus infection have greatly evolved with the approval of preexposure prophylaxis. Despite their effectiveness, a significant gap exists in the initiation and adherence to these preventive measures among cisgender women. This review aims to highlight available implementation models to increase preexposure prophylaxis use and adherence in this population. A narrative review was conducted to identify studies focusing on preexposure prophylaxis use among cisgender women. Ultimately, 15 studies were included and categorized based on their intervention type: behavioral, health clinic, community, pharmacy, technology, or mobile. This review identified several intervention models that improved preexposure prophylaxis use and adherence among cisgender women. Behavioral interventions, such as preexposure prophylaxis-trained nurses and combined counseling with short message service reminders, significantly improved adherence. Health clinic-based interventions demonstrated the importance of regular follow-up and the potential for improved adherence through injectable preexposure prophylaxis. Community interventions highlighted the effectiveness of referral systems and technology-driven approaches, including mHealth interventions and real-time electronic adherence monitoring, to promote preexposure prophylaxis uptake and adherence. Implementing diverse interventions may considerably improve adherence and reduce the human immunodeficiency virus transmission rates in this population.<\/jats:p>","DOI":"10.1177\/03000605251337427","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T19:52:41Z","timestamp":1750881161000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond barriers: The role of preexposure prophylaxis in the prevention of human immunodeficiency virus in women"],"prefix":"10.1177","volume":"53","author":[{"given":"Alex","family":"Dang","sequence":"first","affiliation":[{"name":"University of Illinois Chicago, Retzky College of Pharmacy, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary","family":"Debs","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago, Retzky College of Pharmacy, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johnny","family":"Ruiz","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago, Retzky College of Pharmacy, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Vu","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago, Retzky College of Pharmacy, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7564-0131","authenticated-orcid":false,"given":"Melissa E","family":"Badowski","sequence":"additional","affiliation":[{"name":"University of Illinois Chicago, Retzky College of Pharmacy, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"e_1_3_10_2_2","unstructured":"Fact Sheets | Newsroom | NCHHSTP | CDC [Internet]. PrEP for HIV prevention in the U.S. https:\/\/stacks.cdc.gov\/view\/cdc\/112360 (2021 accessed 25 March 2025)."},{"key":"e_1_3_10_3_2","unstructured":"NIH [Internet]. Antiretroviral therapy to prevent sexual transmission of HIV (treatment as prevention) https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/arv-therapy-as-prevention?view=full (2019 accessed 25 March 2025)."},{"key":"e_1_3_10_4_2","unstructured":"HIV.gov. U.S. Statistics [Internet] https:\/\/www.hiv.gov\/hiv-basics\/overview\/data-and-trends\/statistics (2021 accessed)."},{"key":"e_1_3_10_5_2","unstructured":"UNAIDS. Global HIV & AIDS statistics - fact sheet https:\/\/www.unaids.org\/en\/resources\/fact-sheet (accessed 25 March 2025)."},{"key":"e_1_3_10_6_2","unstructured":"AIDSVu. AIDSVU releases new PrEP data and launches PrEPVu.org a new prep equity platform https:\/\/aidsvu.org\/news-updates\/aidsvu-releases-new-prep-data-and-launches-prepvu-org-a-new-prep-equity-platform\/#:\u223c:text=Overall%20PrEP%20Use%3A 2022%2C%20to%2014%20in%202023 (2024 accessed 25 March 2025)."},{"key":"e_1_3_10_7_2","unstructured":"Periscopic. \u201cA map-based tool to explore trends in PrEP use globally as countries introduce and scale up prep programs.\u201d AVAC: The Global PrEP Tracker data.prepwatch.org\/ (accessed 25 March 2025)."},{"key":"e_1_3_10_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2018.06.005"},{"key":"e_1_3_10_9_2","unstructured":"U.S. Department of Health and Human Services. HHS releases first-ever STI federal implementation plan https:\/\/www.hhs.gov\/about\/news\/2023\/06\/08\/hhs-releases-first-ever-sti-federal-implementation-plan.html#:\u223c:text=STIs%20have%20risen%20dramatically%20between (2023 accessed 25 March 2025)."},{"key":"e_1_3_10_10_2","unstructured":"National Institute on Aging. HIV AIDS and older adults https:\/\/www.nia.nih.gov\/health\/hiv-aids\/hiv-aids-and-older-adults (accessed 25 March 2025)."},{"key":"e_1_3_10_11_2","unstructured":"HIV Surveillance [Internet]. https:\/\/www.cdc.gov\/nchhstp\/director-letters\/cdc-publishes-new-hiv-surveillance-reports.html (2024 accessed 25 March 2025)."},{"key":"e_1_3_10_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003494"},{"key":"e_1_3_10_13_2","unstructured":"Gilead Sciences Inc. Gilead\u2019s twice-yearly lenacapavir demonstrated 100% efficacy and superiority to daily Truvada\u00ae for HIV prevention https:\/\/www.gilead.com\/news\/news-details\/2024\/gileads-twice-yearly-lenacapavir-demonstrated-100-efficacy-and-superiority-to-daily-truvada-for-hiv-prevention (accessed 25 March 2025)."},{"key":"e_1_3_10_14_2","unstructured":"PrEPWatch. The global PrEP tracker https:\/\/data.prepwatch.org\/ (accessed 25 March 2025)."},{"key":"e_1_3_10_15_2","unstructured":"UNAIDS. 2024 Global AIDS report \u2014 the urgency of now: AIDS at a crossroads https:\/\/www.unaids.org\/en\/resources\/documents\/2024\/global-aids-update-2024 (accessed 25 March 2025)."},{"key":"e_1_3_10_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000002814"},{"key":"e_1_3_10_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26189"},{"key":"e_1_3_10_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-022-01482-5"},{"key":"e_1_3_10_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25875"},{"key":"e_1_3_10_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25962"},{"key":"e_1_3_10_21_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002885"},{"key":"e_1_3_10_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25408"},{"key":"e_1_3_10_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25968"},{"key":"e_1_3_10_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(22)00195-3"},{"key":"e_1_3_10_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001980"},{"key":"e_1_3_10_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003447"},{"key":"e_1_3_10_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/16549716.2023.2231256"},{"key":"e_1_3_10_28_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0299168"},{"key":"e_1_3_10_29_2","doi-asserted-by":"crossref","unstructured":"Celum C Hosek S Tsholwana M et al. PrEP uptake persistence adherence and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082 a randomized controlled trial. PLoS Med 2021; 18: e1003670.","DOI":"10.1371\/journal.pmed.1003670"},{"key":"e_1_3_10_30_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06920-4"},{"key":"e_1_3_10_31_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001950"},{"key":"e_1_3_10_32_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305273"},{"key":"e_1_3_10_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07376-5"},{"key":"e_1_3_10_34_2","first-page":"e20877","article-title":"Community-based, rapid HIV screening and pre-exposure prophylaxis initiation: findings from a pilot program","volume":"14","author":"Schaffer DH","year":"2022","unstructured":"Schaffer DH, Sawczuk LM, Zheng H, et\u00a0al. Community-based, rapid HIV screening and pre-exposure prophylaxis initiation: findings from a pilot program. Cureus 2022; 14: e20877.","journal-title":"Cureus"},{"key":"e_1_3_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.whi.2012.09.002"},{"key":"e_1_3_10_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000003803"},{"key":"e_1_3_10_37_2","unstructured":"Gilead Sciences. Study to assess safety and efficacy of lenacapavir and emtricitabine\/tenofovir alafenamide for pre-exposure prophylaxis in adolescent girls and young women at risk of HIV infection (PURPOSE 1) Clinicaltrials.gov identifier: NCT04994509 (2022 accessed 15 July 2023)."},{"key":"e_1_3_10_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.10.005"},{"key":"e_1_3_10_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-021-03494-4"}],"container-title":["Journal of International Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605251337427","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/03000605251337427","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/03000605251337427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:47:37Z","timestamp":1777459657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/03000605251337427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1177\/03000605251337427"],"URL":"https:\/\/doi.org\/10.1177\/03000605251337427","relation":{},"ISSN":["0300-0605","1473-2300"],"issn-type":[{"value":"0300-0605","type":"print"},{"value":"1473-2300","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]},"article-number":"03000605251337427"}}